Document Detail


Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006.
MedLine Citation:
PMID:  20439339     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: We described changes in treatment of colon cancer over time and the impact on survival in The Netherlands in the period 1989-2006.
PATIENTS AND METHODS: All 103,744 patients with invasive colon cancer during 1989-2006 in The Netherlands were included. Data were extracted from The Netherlands Cancer Registry. Trends in treatment over time were analysed and multivariable relative survival analysis was carried out.
RESULTS: The administration of adjuvant chemotherapy in stage III patients <75 years increased from 19% in 1989-1993 to 79% in 2004-2006 and from 1% to 19% in stage III patients ≥75 years. Among stage IV patients, resection rates of the primary tumour decreased from 72% to 63%, while chemotherapy administration increased from 23% to 64% in those <75 years. Survival increased from 52% to 58% in males and from 55% to 58% among females. Stage III patients with adjuvant chemotherapy exhibited a relative excess risk of 0.4 (95% confidence interval 0.4-0.4) compared with those without. Among stage IV patients, resection of primary tumour, palliative chemotherapy, and metastasectomy were important prognostic factors.
CONCLUSIONS: There were substantial improvements in management and survival of colon cancer from 1989 to 2006. Stage III disease patients with colon cancer experienced the largest improvement in survival, most likely related to the increased administration of adjuvant chemotherapy.
Authors:
L N van Steenbergen; M A G Elferink; P Krijnen; V E P P Lemmens; S Siesling; H J T Rutten; D J Richel; H E Karim-Kos; J W W Coebergh;
Related Documents :
16170169 - Explaining differences in attitude toward adjuvant chemotherapy between experienced and...
2001569 - Adjuvant therapy for node-negative breast cancer. the use of prognostic factors in sele...
21699879 - Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in...
2743269 - Adrenal cortical carcinoma.
19410399 - Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal ca...
22148069 - Multiple granulocytic sarcomas in a patient with longstanding complete remission of acu...
10964329 - Overexpression of cathepsin b and urokinase plasminogen activator is associated with in...
1714419 - An alternating chemotherapy combination (macoble) for intermediate and high-grade non-h...
16320559 - Adenocarcinoma of the cervix metastatic from a colon primary and diagnosed from a routi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-03
Journal Detail:
Title:  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO     Volume:  21     ISSN:  1569-8041     ISO Abbreviation:  Ann. Oncol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007735     Medline TA:  Ann Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  2206-12     Citation Subset:  IM    
Affiliation:
Department of Research, Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands. research@ikz.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Justifying terminal care by 'retrospective quality-adjusted life-years'
Next Document:  Incidence of and survival following brain metastases among women with inflammatory breast cancer.